Rochester, MN, United States of America

Zhenkun Lou

This inventor holds 8 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhenkun Lou. Retrieved from https://idiyas.com/inventor/zhenkun-lou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Zhenkun Lou: Innovator in Cancer Research

Introduction

Zhenkun Lou is a prominent inventor based in Rochester, MN (US), known for his significant contributions to cancer research. With a total of 8 patents, he has developed innovative methods and materials that aim to improve cancer detection and treatment.

Latest Patents

One of his latest patents focuses on "Methods and materials for identifying and treating cancers having elevated levels of phosphorylated ubiquitin." This invention provides techniques for identifying mammals, including humans, with cancer cells that exhibit elevated levels of phosphorylated ubiquitin polypeptides. Specifically, it details methods for detecting the presence of cancer cells with increased levels of Y59 phosphorylated ubiquitin polypeptides.

Another notable patent is titled "HEATR1 as a marker for chemoresistance." This invention relates to methods of utilizing HEATR1 expression levels to guide chemotherapy treatment for pancreatic cancer. It highlights that lower HEATR1 expression in pancreatic cancer is associated with resistance to certain chemotherapy treatments. By adjusting treatment based on HEATR1 levels, a better prognosis may be achieved for patients. Furthermore, monitoring HEATR1 expression can provide insights into the long-term prognosis of pancreatic cancer patients.

Career Highlights

Zhenkun Lou is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research in cancer treatment. His work has garnered attention for its potential to significantly impact patient outcomes.

Collaborations

Zhenkun collaborates with esteemed colleagues, including Tongzheng Liu and JungJin Kim, to further enhance the scope and effectiveness of his research.

Conclusion

Zhenkun Lou's innovative work in cancer research exemplifies the critical role of inventors in advancing medical science. His patents not only contribute to the understanding of cancer but also pave the way for improved treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…